Imaging chain pulls out of bankruptcy

Article

Medical Resources has closed the book on Chapter 11—and slammed the door on many of its shareholders. As part of the financial restructuring, holders of $75 million in senior notes will receive approximately 84% of its common stock, with the

Medical Resources has closed the book on Chapter 11-and slammed the door on many of its shareholders. As part of the financial restructuring, holders of $75 million in senior notes will receive approximately 84% of its common stock, with the remaining equity distributed to other creditors and plaintiffs in lawsuits. Pre–Chapter 11 shareholders will receive no distributions, and their shares of common stock will be canceled. With fewer than 300 record holders of its common stock, the company is no longer subject to the reporting requirements of the Securities Exchange Act of 1934. Medical Resources, which owns 70 imaging centers, marked completion of the restructuring by acquiring new MRI and CT scanners for its Springfield (PA) Diagnostic Imaging Center and Sarasota (FL) Outpatient affiliates.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.